Trial studying safety and effects for Thyroid Nodule
Official title The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
ClinicalTrials.gov ID: NCT06929650
What this study is testing
- What it's testing
- The study wants to see if radiofrequency ablation (a heat‑based needle treatment) can safely and feasibly treat small, low‑risk thyroid cancers.
- Who it's for
- Adults with a thyroid cancer nodule that is 2 cm or smaller and considered low‑risk.
- What's involved
- Participants will have imaging scans of the thyroid nodule, then undergo the radiofrequency ablation procedure, followed by three check‑up visits.
- Time commitment
- The study lasts about one year, with follow‑up visits at 4 weeks, 6 months, and 12 months after the procedure.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100. Healthy volunteers may be eligible.
You may be able to join if
- Nodule less than or equal to 2cm in size a. Specifically: Bethesda 5/6
- Their age is ≥18 years and ≤100 years
- Able to provide written consent
- Able to attend required follow-ups as per the protocol
You likely can't join if
- Patients \<18 years old
- Pregnant women
- Any concern for invasive or metastatic thyroid cancer
- Previously treated for thyroid cancer
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.